Khanban, H., Fattahi, E. and Talkhabi, M. (2019) “In vivo administration of G9a inhibitor A366 decreases osteogenic potential of bone marrow-derived mesenchymal stem cells”, EXCLI Journal, 18, pp. 300–309. doi: 10.17179/excli2019-1234.